Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.
Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, Rebell G, Lesher J, Gerlach B, Ponce-De-Leon GF, Ghannoum A, Warner J, Isham N, Elewski B. Ghannoum MA, et al. J Am Acad Dermatol. 2000 Oct;43(4):641-8. doi: 10.1067/mjd.2000.107754. J Am Acad Dermatol. 2000. PMID: 11004620
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB. Scher RK, et al. Among authors: odom rb. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S77-86. doi: 10.1016/s0190-9622(98)70490-6. J Am Acad Dermatol. 1998. PMID: 9631989 Clinical Trial.
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
Rich P, Scher RK, Breneman D, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB, Hilbert J. Rich P, et al. Among authors: odom rb. J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S103-9. doi: 10.1016/s0190-9622(98)70493-1. J Am Acad Dermatol. 1998. PMID: 9631992 Clinical Trial.
Safety of itraconazole pulse therapy for onychomycosis. An update.
De Doncker P, Gupta AK, Cel Rosso JQ, Daniel CR 3rd, Rosen T, Verspeelt J, Marynissen G, Meuleneers L, Moskovitz B, Jacko M, Shear N, Odom RB, Aly R, Scher RK, Elewski BE. De Doncker P, et al. Among authors: odom rb. Postgrad Med. 1999 Jul;Spec No:17-25. Postgrad Med. 1999. PMID: 10492662
Topical metronidazole maintains remissions of rosacea.
Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, Wolf JE Jr, Aly R, Bayles C, Reusser B, Weidner M, Coleman E, Patrignelli R, Tuley MR, Baker MO, Herndon JH Jr, Czernielewski JM. Dahl MV, et al. Among authors: odom rb. Arch Dermatol. 1998 Jun;134(6):679-83. doi: 10.1001/archderm.134.6.679. Arch Dermatol. 1998. PMID: 9645635 Clinical Trial.
New therapies for onychomycosis.
Odom RB. Odom RB. J Am Acad Dermatol. 1996 Sep;35(3 Pt 2):S26-30. doi: 10.1016/s0190-9622(96)90067-5. J Am Acad Dermatol. 1996. PMID: 8784308
94 results